Pembrolizumab And Cryoablation In Urothelial Carcinoma
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This research study is examining the effectiveness of pembrolizumab plus cryoablation on
people with urothelial carcinoma, including bladder cancer, that has spread.